Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 30;20(1):14.
doi: 10.1186/s13024-025-00804-5.

Lewy body diseases and the gut

Affiliations
Review

Lewy body diseases and the gut

Timothy R Sampson et al. Mol Neurodegener. .

Abstract

Gastrointestinal (GI) involvement in Lewy body diseases (LBDs) has been observed since the initial descriptions of patients by James Parkinson. Recent experimental and human observational studies raise the possibility that pathogenic alpha-synuclein (⍺-syn) might develop in the GI tract and subsequently spread to susceptible brain regions. The cellular and mechanistic origins of ⍺-syn propagation in disease are under intense investigation. Experimental LBD models have implicated important contributions from the intrinsic gut microbiome, the intestinal immune system, and environmental toxicants, acting as triggers and modifiers to GI pathologies. Here, we review the primary clinical observations that link GI dysfunctions to LBDs. We first provide an overview of GI anatomy and the cellular repertoire relevant for disease, with a focus on luminal-sensing cells of the intestinal epithelium including enteroendocrine cells that express ⍺-syn and make direct contact with nerves. We describe interactions within the GI tract with resident microbes and exogenous toxicants, and how these may directly contribute to ⍺-syn pathology along with related metabolic and immunological responses. Finally, critical knowledge gaps in the field are highlighted, focusing on pivotal questions that remain some 200 years after the first descriptions of GI tract dysfunction in LBDs. We predict that a better understanding of how pathophysiologies in the gut influence disease risk and progression will accelerate discoveries that will lead to a deeper overall mechanistic understanding of disease and potential therapeutic strategies targeting the gut-brain axis to delay, arrest, or prevent disease progression.

Keywords: Dementia with Lewy bodies; Gastrointestinal tract; Immunity; Inflammation; Microbiome; Parkinson’s disease; Parkinson’s disease dementia.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: All authors give their consent to publish. Competing interests: T.R.S. is a listed inventor on institutionally-assigned IP surrounding the microbiome and PD. M.G.T. has served as a member of The Michael J. Fox Foundation Scientific Advisory Board and serves on the Parkinson’s Foundation Scientific Advisory Board, the Weston Family Foundation Advisory Board, the Alzheimer’s Association Medical and Scientific Advisory Group, and as advisor for NysnoBio, IMMvention, Ventus, iMetabolic Pharma, Longevity Inc, Merck, NovoNordisk, Forward Therapeutics, Jaya, Longeveron, and Alnylam. She has received grants from MJFF/ASAP, Parkinson’s Foundation, and the National Institutes of Health (NIH). She is Editor-in-Chief for Nature Partner Journal Parkinson’s Disease, and serves as Associate Editor for Science Advances, Alzheimer’s & Dementia: Translational Research and Clinical Interventions, and the Journal of Neuroinflammation. A.B.W. has served as a member of The Michael J. Fox Executive Foundation (MJFF) Scientific Advisory Board and is a paid consultant for SciNeuro, Inc, and has been a paid consultant for EscapeBio Inc.; and has received research grants from Biogen Inc. and EscapeBio, Inc., as well as MJFF, ASAP Foundation, Parkinson’s Foundation, and the National Institutes of Health (NIH). A.B.W. is part owner of a series of LRRK2 kinase inhibitors (WO 2013166276) and part owner of induced-pluripotent stem cell lines of early-onset PD distributed by Cedars Sinai. R.A.L. receives authorship royalties from UpToDate.

Figures

Fig. 1
Fig. 1
Graphical representation of the major neural pathways connecting the GI tract and brain. The vagus nerve contains both afferent and efferent fibers and innervates the esophagus, stomach, small intestine and proximal colon. Branched endings represent axonal endings. Cell bodies of the motor branch of the vagus reside in the dorsal motor nucleus of the vagus and those of the sensory branch are in the nodose ganglia. The celiac, superior and inferior mesenteric ganglia integrate sensory and motor inputs to the upper and lower GI tract and pathways carry signals to and from the distal colon and rectum. All nerves contain ⍺-syn and are subject to templating and propagating misfolded ⍺-syn thus representing routes of transport to susceptible brain regions. The vagus nerve richly innervates the upper GI tract and provides a direct route for ⍺-syn spread to the brain. (Modified from [33] and [34])
Fig. 2
Fig. 2
Diagram depicting the arrangement of the enteric nervous system (ENS) in the gut. In the small and large intestines, nerve cell bodies reside in ganglia of the myenteric or submucosal plexi. The myenteric plexus lies between the circular and longitudinal muscle layers of the bowel wall. Soma of the submucosal plexus are found in ganglia between the muscularis mucosa and circular muscle layer and extend neurites to crypts and villi of the bowel wall. Enteric and vagal fibers abut but do not penetrate the intestinal mucosa. In this location, any misfolded ⍺-syn (red dots) of mucosal origin (e.g., EECs, green) may spread to the nervous system. (Modified from [35])
Fig. 3
Fig. 3
Co-culture of intestinal organoids and sensory neurons. A Cartoon depicting an experiment in which intestinal organoids from a transgenic mouse expressing human ⍺-syn (tgSNCAA53T) are co-cultured with nodose neurons from mice devoid of ⍺-syn (Snca−/−). Enteroendocrine cells (green) containing ⍺-syn (red) are dispersed among other cell types which are mostly enterocytes. Grown from intestinal crypt fragments or isolated stem cells, organoids form spheroids comprised of a single layer of mucosa surrounding a central lumen. B Nodose ganglion neurons (cyan) grown in gut organoid co-culture often contact EECs (green). Spread of ⍺-syn from tgSNCAA53T EECs to nodose neurons from Snca−/− mice has been demonstrated in culture [75]. This transer is depicted in the representative confocal images (scale bar is 3 μm)
Fig. 4
Fig. 4
Publications supporting key concepts highlighted in this review for GI involvement in the pathogenesis and pathophysiology of Lewy body diseases

References

    1. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223–36 discussion 2. - PubMed
    1. Goetz CG. Charcot on Parkinson’s disease. Mov Disord. 1986;1(1):27–32. - PubMed
    1. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2003;2(2):107–16. - PubMed
    1. Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14(6):625–39. - PubMed
    1. Sakakibara R, Odaka T, Uchiyama T, Asahina M, Yamaguchi K, Yamaguchi T, et al. Colonic transit time and rectoanal videomanometry in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2003;74(2):268–72. - PMC - PubMed

MeSH terms

Substances